ArticleGlobal health action2025
Validation of the Child Development Card (KKA) as a growth and development tool for stunted and normal children in West Java, Indonesia.
Article in Global health action, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStunting remains a major public health issue in Indonesia, and the limitations of anthropometric measures highlight the need for alternative tools such as the Child Development Card (KKA).
objectivesThis study aimed to determine the validity and reliability of the KKA as a tool to measure the growth and development of stunted and normal children through direct observation.
methodsThe revised KKA was administered to 262 children aged 13-60 months, including 174 normal and 88 stunted children, from three stunting-locus regencies in West Java Province, Indonesia. The data were analysed using content validity, the Guttman coefficient of reproducibility, and Cronbach alpha to develop a revised KKA observation guideline.
resultsA total of 15 conceptually inappropriate items were revised, and an observation guideline was developed as a guide for the direct observation of children. In each aspect of growth and development, age range, and sample category, the reproducibility and scalability coefficients showed values of >0.9 and >0.6, respectively. Meanwhile, Cronbach alpha values for each age range and sample category were >0.7.
conclusionThe revised KKA demonstrated both validity and reliability as a tool for the detection, monitoring, and early intervention of growth and developmental delays in children with stunted as well as those with normal development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.